Nasdaq Slno News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq slno. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Slno Today - Breaking & Trending Today

Insider Selling: Soleno Therapeutics, Inc. (NASDAQ:SLNO) Major Shareholder Sells $35,850,000.00 in Stock

Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) major shareholder Vivo Opportunity, Llc sold 750,000 shares of the firm’s stock in a transaction on Monday, April 29th. The shares were sold at an average price of $47.80, for a total transaction of $35,850,000.00. Following the completion of the transaction, the insider now directly owns 7,668,093 […] ....

New Zealand General , New Zealand , Stifel Nicolaus , Piper Sandler , Soleno Therapeutics Inc , Allspring Global Investments Holdings , Cannon Global Investment Management , Wellington Management Group , Avoro Capital Advisors , Carlyle Group Inc , Securities Exchange Commission , Vivo Opportunity Llc , Soleno Therapeutics , Get Free Report , Vivo Opportunity , Exchange Commission , Global Investments Holdings , Global Investment Management , Management Group , Diazoxide Choline Extended Release , Soleno Therapeutics Daily , Nasdaq Slno , Insider Trading , Nsider Trades ,

Soleno Therapeutics Announces Pricing of Approximately $138

REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) Soleno Therapeutics, Inc. (Nasdaq: SLNO), (“Soleno” or the “Company”), a clinical-stage. ....

New York , United States , Piper Sandler , Brian Ritchie , Prospectus Department , Laidlaw Company United Kingdom Ltd , Lifesci Advisors , Company Annual Report On Form , Securities Exchange , Equity Syndicate Department , Soleno Therapeutics Inc , Oppenheimer Co , Guggenheim Securities , Cantor Fitzgerald Co , Exchange Commission , Piper Sandler Co , Cantor Fitzgerald , United Kingdom , Prader Willi Syndrome , Soleno Therapeutics , Securities Exchange Act , Annual Report , Sci Advisors , Nasdaq Slno , Soleno Therapeutics ,

Soleno Therapeutics Receives Breakthrough Therapy

First Ever Breakthrough Designation for a Drug Being Developed for PWS Designation is Based on Data from the Phase 3 Program for DCCR Planned. ....

United States , Brian Ritchie , Manish Bhatnagar , Foundation For Prader Willi Research , Drug Administration , Lifesci Advisors , Prader Willi Syndrome Association United States , Securities Exchange , Soleno Therapeutics Inc , First Ever Breakthrough Designation , Drug Being Developed , New Drug Application , Breakthrough Therapy Designation , Chief Executive Officer , Therapy Designation , With Breakthrough Therapy Designation , Orphan Drug Designation , Fast Track Designation , Prader Willi Research , Diazoxide Choline , Fast Track , Breakthrough Designations , Soleno Therapeutics , Securities Exchange Act , Sci Advisors , Nasdaq Slno ,

Soleno Therapeutics, Inc. (NASDAQ:SLNO) CEO Sells $784,633.20 in Stock

Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) CEO Bhatnagar Anish sold 18,980 shares of the firm’s stock in a transaction on Monday, April 1st. The stock was sold at an average price of $41.34, for a total value of $784,633.20. Following the sale, the chief executive officer now owns 152,790 shares in the company, […] ....

Stifel Nicolaus , Bhatnagar Anish , Piper Sandler , Silverarc Capital Management , Securities Exchange Commission , Schonfeld Strategic Advisors , Emerald Mutual Fund Advisers , Walleye Capital , Soleno Therapeutics Inc , Carlyle Group Inc , Soleno Therapeutics , Get Free Report , Exchange Commission , Strategic Advisors , Mutual Fund Advisers Trust , Diazoxide Choline Extended Release , Soleno Therapeutics Daily , Nasdaq Slno , Insider Trading , Nsider Trades ,

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Kristen Yen Sells 2,218 Shares

Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) insider Kristen Yen sold 2,218 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $41.34, for a total transaction of $91,692.12. Following the transaction, the insider now directly owns 23,422 shares in the company, valued at […] ....

Stifel Nicolaus , Piper Sandler , Carlyle Group Inc , Soleno Therapeutics Inc , Nantahala Capital Management , Vivo Capital , Worth Venture Partners , Perceptive Advisors , Soleno Therapeutics Company Profile , Soleno Therapeutics , Get Free Report , Kristen Yen , Capital Management , Diazoxide Choline Extended Release , Soleno Therapeutics Daily , Nasdaq Slno , Insider Trading , Nsider Trades ,